Provenge, It Isn’t Over Priced, Its Actually A Bargain Basement Product
There remain for many people questions about Provenge. The most common question I hear is about the financial cost of the treatment for what has been described as “only 4 months of life extension for [...]
Harold E. Varmus, M.D. Nominated to be the Director of the National Cancer Institute – Is It Good or Bad for Cancer Survivors?
President Barack Obama has nominated Harold E. Varmus, M.D., the Nobel Prize-winning scientist for studies showing how certain normal genes could cause cancer when they went awry; to serve as the 14th director of the [...]
Timing IADT, Can “On Cycle” Time Periods Predict Outcomes?
A study by Yu et al., of men with a rising PSA after failed radical prostatectomy or radiation therapy who were placed on intermittent androgen deprivation therapy (IADT) indicated that the length of their first [...]
Cancer and Organ Donation – A Surprise Answer
Don Greggs, a long time prostate cancer survivor, recently asked his niece if people with cancer are able to donate organs at the time of their death. His niece who has worked in the organ [...]
Long-term Outcomes of Salvage Radiotherapy for PSA-Recurrent Prostate Cancer: Does It Work?
We know that approximately one-third of all men who elect to have a radical prostatectomy for localized prostate cancer will ultimately experience a biochemical (PSA) recurrence. Researchers at the Department of Urology, Loyola University Medical [...]
FDA Probes Breast Cancer Risk of Avodart & Proscar
The Food and Drug Administration (FDA) has announced that it is looking into reports that Glaxo Smith Kline’s prostate drug Avodart and Merck & Co’s prostate drug Proscar may be contributing to an increase of [...]